US 10533227
Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
granted A61PA61P35/00
Quick answer
US patent 10533227 (Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer) held by The Board of Regents of the University of Texas System expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P35/00